Demyelination and Remyelination: From Mechanism to Therapy
Demyelinating diseases and disorders affect millions of people worldwide. New breakthroughs in basic science research on the white matter microenvironment and oligodendrocyte precursor cell development have provided novel potential sites of action for therapeutics. Translation of these discoveries into biomarkers to predict clinical outcomes, and into biologics that can modulate myelination utilizing these pathways, may transform the treatment of currently incurable conditions.
This one-day, translational conference will present recent findings in remyelination and repair from disease models and clinical trials, new techniques for imaging myelination changes in the brain and for screening molecular targets, and emerging therapeutics that promote remyelination.
Call for Abstracts and Travel Fellowship Applications: Deadline extended until May 5.
Select poster abstracts will be chosen for oral presentation. See website for details.